Follow
Adrian L Harris
Adrian L Harris
Professor of Medical Oncology, Oxford University
Verified email at oncology.ox.ac.uk
Title
Cited by
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
12414*2021
Hypoxia—a key regulatory factor in tumour growth
AL Harris
Nature reviews cancer 2 (1), 38-47, 2002
61092002
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 366 (9503), 2087-2106, 2005
59632005
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
C Sotiriou, SY Neo, LM McShane, EL Korn, PM Long, A Jazaeri, P Martiat, ...
Proceedings of the National Academy of Sciences 100 (18), 10393-10398, 2003
26712003
Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma
CH Lawrie, S Gal, HM Dunlop, B Pushkaran, AP Liggins, K Pulford, ...
British journal of haematology 141 (5), 672-675, 2008
23452008
Polychemotherapy for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 352 (9132), 930-942, 1998
21371998
The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
KL Talks, H Turley, KC Gatter, PH Maxwell, CW Pugh, PJ Ratcliffe, ...
The American journal of pathology 157 (2), 411-421, 2000
17112000
Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma
RD Leek, CE Lewis, R Whitehouse, M Greenall, J Clarke, AL Harris
Cancer research 56 (20), 4625-4629, 1996
15571996
Hypoxia-inducible expression of tumor-associated carbonic anhydrases
CC Wykoff, NJP Beasley, PH Watson, KJ Turner, J Pastorek, A Sibtain, ...
Cancer research 60 (24), 7075-7083, 2000
15502000
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
GJFSB Bates, CLRD Han, JFHAL Garcia, AH Banham
Journal of clinical oncology 24 (34), 5373-5380, 2006
13652006
Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis
RA Dragovic, C Gardiner, AS Brooks, DS Tannetta, DJP Ferguson, P Hole, ...
Nanomedicine: Nanotechnology, Biology and Medicine 7 (6), 780-788, 2011
13522011
Increased expression of mutant forms of p53 oncogene in primary lung cancer
R Iggo, J Bartek, D Lane, K Gatter, AL Harris
The Lancet 335 (8691), 675-679, 1990
13511990
Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor
RJ Appelhoff, YM Tian, RR Raval, H Turley, AL Harris, CW Pugh, ...
Journal of Biological Chemistry 279 (37), 38458-38465, 2004
12572004
Effects of radiotherapy and surgery in early breast cancer—an overview of the randomized trials
Early Breast Cancer Trialists' Collaborative Group
New England Journal of Medicine 333 (22), 1444-1456, 1995
12121995
Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelialá…
M Relf, S LeJeune, PAE Scott, S Fox, K Smith, R Leek, A Moghaddam, ...
Cancer research 57 (5), 963-969, 1997
11761997
Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer
J Richard, C Sainsbury, GK Needham, JR Farndon, AJ Malcolm, ...
The Lancet 329 (8547), 1398-1402, 1987
11471987
Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma
RR Raval, KW Lau, MGB Tran, HM Sowter, SJ Mandriota, JL Li, CW Pugh, ...
Molecular and cellular biology 25 (13), 5675-5686, 2005
11352005
SYSTEMIC TREATMENT OF EARLY BREAST-CANCER BY HORMONAL, CYTOTOXIC, OR IMMUNE THERAPY-133 RANDOMIZED TRIALS INVOLVING 31000 RECURRENCES AND 24000 DEATHS AMONG 75000 WOMEN. 2.
O Abe, R Abe, K Asaishi, K Enomoto, T Hattori, Y Ino, K Kikuchi, ...
Lancet 339 (8785), 71-85, 1992
10851992
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
C Desmedt, F Piette, S Loi, Y Wang, F Lallemand, B Haibe-Kains, G Viale, ...
Clinical cancer research 13 (11), 3207-3214, 2007
10782007
How cancer metabolism is tuned for proliferation and vulnerable to disruption
A Schulze, AL Harris
Nature 491 (7424), 364-373, 2012
9752012
The system can't perform the operation now. Try again later.
Articles 1–20